🇺🇸 FDA
Patent

US 7772259

1,2,4-Oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

granted A61KA61K31/4245A61K31/4439

Quick answer

US patent 7772259 (1,2,4-Oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease) held by PTC THERAPEUTICS, INC. expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K31/4245, A61K31/4439, A61K31/454, A61K31/4545